Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA

Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA

Two randomized, placebo-controlled studies evaluated the pulmonary function safety of onabotulinumtoxinA (onabotA) for treatment of upper and/or lower limb spasticity. Patients with stable baseline respiratory status received one or two treatments with placebo, 240 U, or 360 U of onabotA. Pulmonary...

Full description

Bibliographic Details
Main Authors: Ziyad Ayyoub, Allison Brashear, Marta Banach, Robert Schoene, William Stringer, Terry Boodhoo, Irina Yushmanova, Rozalina Dimitrova, Mitchell F. Brin
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Toxins
Subjects:
onabotulinumtoxinA
botulinum toxin type A
pulmonary function testing
spasticity
respiratory function
forced vital capacity
Online Access:https://www.mdpi.com/2072-6651/12/10/661

Internet

https://www.mdpi.com/2072-6651/12/10/661

Similar Items